Aurobindo Pharma faces CA Suit in US for concealing facts Medical Dialogues Bureau9 April 2020 8:06 AM GMTHyderabad: A class-action suit has been filed against some drug manufacturers, including Aurobindo Pharma and Emcure Pharmaceuticals, in a USA court fo...
Zydus gets USFDA final approval for Imatinib Mesylate Tablets Medical Dialogues Bureau9 April 2020 7:31 AM GMTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Imatinib Mesylate Tablets, 100 mg and 400 mg. (US RLD: Gleevec® Tablets)Th...
With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India Medical Dialogues Bureau9 April 2020 7:00 AM GMTNew Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative brea...
Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT Medical Dialogues Bureau9 April 2020 4:30 AM GMTNew York: President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to e...
Merck KEYTRUDA gets USFDA priority review for its Second Application Medical Dialogues Bureau9 April 2020 3:30 AM GMTKenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted and...
Swasth Ke Sipahi delivering essential services and medicines at doorstep of patients and elderly under PMBJP Medical Dialogues Bureau9 April 2020 3:30 AM GMTDelhi: Pharmacists, popularly known as 'Swasth Ke Sipahi', of Pradhan Mantri Jan Aushadhi Kendra, are delivering essential services and medicines at th...
Jubilant Life Sciences Karnataka plant shut on coronavirus scare Medical Dialogues Bureau8 April 2020 8:45 AM GMTMysuru: The drug-making plant of pharma major Jubilant Life Sciences at Nanjangud near here has been shut down after it was suspected to have been infe...
Zydus gets USFDA final approval for Perphenazine Tablets USP Medical Dialogues Bureau8 April 2020 7:26 AM GMTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg. (US RLD: Trilafon® T...
DSM India co-funds UNDP COVID19 healthcare initiative to procure and deploy ventilators Medical Dialogues Bureau8 April 2020 4:30 AM GMTMumbai: Given the acute need to urgently supplement critical hospital equipment in the coming months, DSM India has partnered with the United Nations D...
Coronavirus Outbreak: Govt to grant licence to industrial manufacturers to produce oxygen for medical use Medical Dialogues Bureau8 April 2020 4:30 AM GMTNew Delhi: The Drug Controller General of India (DCGI) has decided to grant a licence to manufacturers of industrial oxygen to produce oxygen for medic...
Coronavirus: India to export hydroxychloroquine on case-by-case basis; Rahul Gandhi says ensure Indians get it first Medical Dialogues Bureau8 April 2020 3:30 AM GMTHydroxychloroquine is an old and inexpensive drug used to treat malaria.
IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19 Medical Dialogues Bureau7 April 2020 10:00 AM GMTIPA acknowledges the relentless efforts by the employees in the pharma manufacturing industry
